ASHLEY KNUTSON: Open Payments
NPI 1942683297 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 57 payments from 12 companies in 2025. Trend: 2023 $2,368 · 2024 $1,275 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $346 |
| Novo Nordisk Inc | 7 | $147 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Indivior Inc. | 3 | $64 |
| Viatris Specialty LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
Products named: VRAYLAR, UBRELVY, TRELEGY ELLIPTA, REXULTI, Wegovy, QULIPTA, SUBLOCADE, YUPELRI.
Industry payments across NY — which companies pay providers there.
